Pilianidis, Georgios, Georgia Papanastasiou, Pinelopi Tikoudi, Andreas Themistocleous, Georgios Farmakis, and Konstantinos Dolianitis. “Can Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors Be Avoided in COVID-19 and Other Acute Infections?”. European Journal of Case Reports in Internal Medicine 11, no. 3 (February 2, 2024). Accessed April 18, 2024. https://www.ejcrim.com/index.php/EJCRIM/article/view/4282.